Palomino Laboratories (PALX) Cash from Financing Activities (2023 - 2025)

Palomino Laboratories (PALX) has 3 years of Cash from Financing Activities data on file, last reported at $8.1 million in Q3 2025.

• For the quarter ending Q3 2025, Cash from Financing Activities rose 40476.29% year-over-year to $8.1 million; the trailing twelve-month figure through Sep 2025 stood at $8.3 million (changed N/A YoY), and the FY2024 full-year result was $195437.0, up 146.58% from the prior year.
• Cash from Financing Activities grew to $8.1 million in Q3 2025, from $19980.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $8.1 million in Q3 2025 to a low of $20.0 in Q1 2025.
• A 3-year average of $1.4 million and a median of $38404.5 in 2023 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities surged 155.0% in 2024 and soared 40476.29% in 2025, its largest moves.
• Tracing PALX's Cash from Financing Activities over 3 years: stood at $56766.0 in 2023, then surged by 155.0% to $144753.0 in 2024, then jumped by 5518.33% to $8.1 million in 2025.
• Business Quant data shows PALX's Cash from Financing Activities at $8.1 million in Q3 2025, $19980.0 in Q2 2025, and $20.0 in Q1 2025.